Chronic Hepatitis C
HEPATITIS C --- Navigation Topics
• Top New Articles on HCV
• All HCV Articles by Topic ( A to Z )
• HCV Basics
• HIV-HCV Coinfection
• FDA-approved Treatments for HCV
- Roferon A (interferon alfa-2a)
- Intron A (interferon alfa-2b)
- Infergen (consensus interferon)
- Pegasys (peginterferon alfa-2a)
- PegIntron (peginterferon alfa-2b)
- Copegus / Rebetol (ribavirin)
- Intron A + Rebetol
- Roferon A + Ribavirin
- Pegasys + Copegus
- PegIntron + Rebetol
• Treatment Guidelines for HCV
• Experimental Treatments for HCV
• Recent Research Conference Reports
• Tests for HCV
• Liver-related Complications
• Drug-related Adverse Events
• Doctor Is In 'Q and A' for HCV
• Library of CME Programs
• E-mail Update - Sign Up
• About Us - Contact Us
_______________
Kidney Transplantation / Kidney Disorders
HCV Treatment Response Persists after
Kidney Transplantation
12/01/06
Initial HCV Response in Patients with End Stage
Renal Disease
Treated with Pegasys Plus Ribavirin
- 5/23/06
Combination Therapy of Low Dose Ribavirin and Pegylated Interferon for Patients with HCV and End-Stage
Renal Disease
on Dialysis
- 6/01/05
Liver Fibrosis Progression Is Accelerated in
Renal Transplant
Patients Receiving Ribavirin Monotherapy for Chronic Hepatitis C
- 3/30/05
The Effect of Hepatitis C Virus Infection on Mortality in
Kidney Dialysis
- 2/09/05
Outcome of Hepatitis C Virus-infected
Kidney Transplant
Candidates Who Remain on the Waiting List
- 1/21/05
HIV AND AIDS
|
HEPATITIS B
|
HEPATITIS C
|
HIV / HBV CO-INFECTION
|
HIV / HCV CO-INFECTION
|
HEALTH AND TECHNOLOGY
|
TESTS
|
INTERNET CONFERENCE REPORTS
|
TELECONFERENCES
|
LINKS
|
ABOUT US
|
CONTACT US
